Screenig for Fabry disease in renal transplant patients(Monitoring of mulberry body and mulberry cell)

Screenig for Fabry disease in renal transplant patients(Monitoring of mulberry body and mulberry cell) - Screenig for Fabry disease in renal transplant patients(Monitoring of mulberry body and mulberry cell)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023534

Enrollment

150

Registered

2016-08-08

Start date

2016-08-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fabry disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: renal transplant patients gave written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
mulberry body, mulberry cell, alpha-galactosidase A activity	—

Countries

Japan

Contacts

Public ContactAyumi Funabiki

Takatsuki General Hospital Endocrinology and Metabolism

funabiki@ajk.takatsuki-hp.or.jp072-681-3801

Outcome results